{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:53:09Z","timestamp":1791982389688,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009617","name":"Putian Science and Technology Bureau","doi-asserted-by":"publisher","award":["2024SJYL070"],"award-info":[{"award-number":["2024SJYL070"]}],"id":[{"id":"10.13039\/501100009617","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neoadjuvant immunochemotherapy (nICT) followed by esophagectomy has become the standard treatment for locally advanced esophageal squamous cell carcinoma (LA\u2013ESCC). However, severe postoperative complications remain a significant clinical concern. The prognostic nutritional index (PNI), reflecting both nutritional and inflammatory status, may identify patients at elevated risk for complications. This study aimed to investigate the dose\u2013response relationship between preoperative PNI and severe postoperative complications, identify potential thresholds for risk stratification, and explore heterogeneity by pathological response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included 134 consecutive patients with LA\u2013ESCC who received nICT followed by radical esophagectomy. Preoperative PNI was calculated as serum albumin (g\/L)\u2009+\u20095 \u00d7 total lymphocyte count (\u00d710\u2079\/L). The primary outcome was severe postoperative complications (SPCs). Multivariable logistic regression, restricted cubic spline analysis, threshold effect analysis, and subgroup analyses were performed to evaluate the independent association of PNI and explore nonlinear relationships.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      SPCs occurred in 29 patients (21.6%). Multivariable analysis demonstrated that preoperative PNI was independently associated with SPCs (adjusted OR from the primary parsimonious model\u2009=\u20090.86, 95%CI: 0.78\u20130.96,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.006). When PNI was categorized into quartiles, compared with Q1, the adjusted ORs for Q2, Q3, and Q4 were 0.22 (95% CI: 0.06\u20130.75,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.016), 0.11 (95% CI: 0.03\u20130.46,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003), and 0.29 (95% CI: 0.08\u20131.06,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.061), respectively, with a significant trend across quartiles (P for trend\u2009=\u20090.016). Restricted cubic spline analysis revealed a nonlinear \u201cL\u2013shaped\u201d relationship between PNI and SPCs (P for non\u2013linearity\u2009=\u20090.045). Threshold effect analysis identified 50.00 as the inflection point: below this threshold, each unit increase in PNI was associated with a 25% reduction in SPC risk (OR\u2009=\u20090.75, 95% CI: 0.594\u20130.936,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.011); above this threshold, no significant association was observed (OR\u2009=\u20091.09, 95% CI: 0.872\u20131.372,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.438). Subgroup analysis revealed significant heterogeneity by pathological response (P for interaction\u2009=\u20090.011): the protective effect of higher PNI was pronounced in non\u2013pCR patients (OR\u2009=\u20090.80, 95% CI: 0.69\u20130.92) but absent in patients achieving pCR (OR\u2009=\u20091.06, 95% CI: 0.88\u20131.28).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Preoperative PNI is independently associated with severe postoperative complications in LA\u2013ESCC patients receiving nICT, exhibiting a nonlinear \u201cL\u2013shaped\u201d relationship with a threshold of 50.00. The observed interaction with pCR status is exploratory and hypothesis\u2013generating. Future prospective studies are needed to confirm these findings before clinical implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13019-026-04511-0","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T22:25:13Z","timestamp":1784413513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic nutritional index is associated with severe postoperative complications after neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma: a retrospective cohort study with threshold effect analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Qiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongxiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,19]]},"reference":[{"issue":"3","key":"4511_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"4511_CR2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cac2.12197","volume":"41","author":"H Qiu","year":"2021","unstructured":"Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time\u2013trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond). 2021;41(10):1037\u201348. https:\/\/doi.org\/10.1002\/cac2.12197.","journal-title":"Cancer Commun (Lond)"},{"issue":"9","key":"4511_CR3","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1136\/gutjnl-2020-321600","volume":"69","author":"M Arnold","year":"2020","unstructured":"Arnold M, Ferlay J, van Berge Henegouwen MI, Soerjomataram I. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 2020;69(9):1564\u201371. https:\/\/doi.org\/10.1136\/gutjnl-2020-321600 . Epub 2020 Jun 30. PMID: 32606208.","journal-title":"Gut"},{"issue":"9864","key":"4511_CR4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","volume":"381","author":"A Pennathur","year":"2013","unstructured":"Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400\u201312. doi: 10.1016\/S0140\u20136736(12)60643\u20136. PMID: 23374478.","journal-title":"Lancet"},{"issue":"8","key":"4511_CR5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/jamasurg.2021.2373","volume":"156","author":"H Yang","year":"2021","unstructured":"Yang H, Liu H, Chen Y, Zhu C, Fang W, Yu Z, et al. Long\u2013term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: the NEOCRTEC5010 randomized clinical trial. JAMA Surg. 2021;156(8):721\u20139. https:\/\/doi.org\/10.1001\/jamasurg.2021.2373.","journal-title":"JAMA Surg"},{"issue":"18","key":"4511_CR6","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1200\/JCO.20.03614","volume":"39","author":"BM Eyck","year":"2021","unstructured":"Eyck BM, van Lanschot JJB, Hulshof MCCM, van der Wilk BJ, Shapiro J, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, van Laarhoven HWM, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, Cuesta MA, Blaisse RJB, Busch OR, Creemers GM, Punt CJA, Plukker JTM, Verheul HMW, Spillenaar Bilgen EJ, van der Sangen MJC, Rozema T, Ten Kate FJW, Beukema JC, Piet AHM, van Rij CM, Reinders JG, Tilanus HW, Steyerberg EW, van der Gaast A, CROSS Study Group. Ten\u2013Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial. J Clin Oncol. 2021;39(18):1995\u20132004. https:\/\/doi.org\/10.1200\/JCO.20.03614 . Epub 2021 Apr 23. PMID: 33891478.","journal-title":"J Clin Oncol"},{"key":"4511_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1764960","volume":"17","author":"M Sun","year":"2026","unstructured":"Sun M, Yang P, Qi L, Yang T, Wang W, Yu Y, et al. Efficacy and safety of neoadjuvant immunotherapy in locally advanced resectable esophageal squamous cell carcinoma: a network meta\u2013analysis and real\u2013world study. Front Immunol. 2026;17:1764960. https:\/\/doi.org\/10.3389\/fimmu.2026.1764960.","journal-title":"Front Immunol"},{"issue":"9","key":"4511_CR8","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1038\/s41591-024-03064-w","volume":"30","author":"J Qin","year":"2024","unstructured":"Qin J, Xue L, Hao A, Guo X, Jiang T, Ni Y, Liu S, Chen Y, Jiang H, Zhang C, Kang M, Lin J, Li H, Li C, Tian H, Li L, Fu J, Zhang Y, Ma J, Wang X, Fu M, Yang H, Yang Z, Han Y, Chen L, Tan L, Dai T, Liao Y, Zhang W, Li B, Chen Q, Guo S, Qi Y, Wei L, Li Z, Tian Z, Kang X, Zhang R, Li Y, Wang Z, Chen X, Hou Z, Zheng R, Zhu W, He J, Li Y. Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT\u2013NEO\/NCCES01 trial. Nat Med. 2024;30(9):2549\u201357. https:\/\/doi.org\/10.1038\/s41591-024-03064-w . Epub 2024 Jul 2. PMID: 38956195; PMCID: PMC11405280.","journal-title":"Nat Med"},{"issue":"10","key":"4511_CR9","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/cac2.12604","volume":"44","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Liang G, Yuan D, Liu X, Ba Y, Qin Z, et al. Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial. Cancer Commun (Lond). 2024;44(10):1214\u201327. https:\/\/doi.org\/10.1002\/cac2.12604.","journal-title":"Cancer Commun (Lond)"},{"key":"4511_CR10","doi-asserted-by":"publisher","first-page":"1573597","DOI":"10.3389\/fonc.2025.1573597","volume":"15","author":"Y Li","year":"2025","unstructured":"Li Y, Xiao G, Yang B, Hong Y, Chen Z, Gu L, Kong C, Zhao L, Zhu Z, Xu Q, Chen Y, Jiang M, Zhu X, Jiang N. Impact of neoadjuvant immunotherapy combined with chemotherapy or chemoradiotherapy on postoperative safety in locally advanced esophageal squamous cell carcinoma: a propensity score\u2013matched retrospective cohort study. Front Oncol. 2025;15:1573597. https:\/\/doi.org\/10.3389\/fonc.2025.1573597 . PMID: 40469177; PMCID: PMC12133542.","journal-title":"Front Oncol"},{"key":"4511_CR11","doi-asserted-by":"publisher","unstructured":"van der Werf LR, Busweiler LAD, van Sandick JW, van Berge Henegouwen MI, Wijnhoven BPL, Dutch Upper GI, Cancer Audit (DUCA) group. Reporting National Outcomes After Esophagectomy and Gastrectomy According to the Esophageal Complications Consensus Group (ECCG). Ann Surg. 2020;271(6):1095\u20131101. https:\/\/doi.org\/10.1097\/SLA.0000000000003210. PMID: 30676381.","DOI":"10.1097\/SLA.0000000000003210"},{"issue":"9","key":"4511_CR12","doi-asserted-by":"publisher","first-page":"6851","DOI":"10.1245\/s10434-025-17674-2","volume":"32","author":"E Putila","year":"2025","unstructured":"Putila E, Helminen O, Helmi\u00f6 M, Huhta H, Jalkanen A, Junttila A, Kallio R, Koivukangas V, Kokkola A, Lietzen E, Louhimo J, Meril\u00e4inen S, Pohjanen VM, Rantanen T, Ristim\u00e4ki A, R\u00e4s\u00e4nen JV, Saarnio J, Sihvo E, Toikkanen V, Tyrv\u00e4inen T, Valtola A, Kauppila JH, FINEGO Group. Comparing Gastrectomy Complications Consensus Group (GCCG) and Esophagectomy Complications Consensus Group (ECCG) Classifications in Reporting Postoperative Complications After Gastrectomy: A Population\u2013Based Nationwide Study in Finland. Ann Surg Oncol. 2025;32(9):6851\u20137. https:\/\/doi.org\/10.1245\/s10434-025-17674-2 . Epub 2025 Jun 23. PMID: 40549092; PMCID: PMC12317864.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"4511_CR13","first-page":"1001","volume":"85","author":"T Onodera","year":"1984","unstructured":"Onodera T, Goseki N, Kosaki G. [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi. 1984;85(9):1001\u20135. Japanese. PMID: 6438478.","journal-title":"Nihon Geka Gakkai Zasshi"},{"issue":"1","key":"4511_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13018-024-04771-3","volume":"19","author":"Z Huang","year":"2024","unstructured":"Huang Z, Wang H, Da Y, Liu S, Zheng W, Li F. Do nutritional assessment tools (PNI, CONUT, GNRI) predict adverse events after spinal surgeries? A systematic review and meta\u2013analysis. J Orthop Surg Res. 2024;19(1):289. https:\/\/doi.org\/10.1186\/s13018-024-04771-3 . PMID: 38735935; PMCID: PMC11089772.","journal-title":"J Orthop Surg Res"},{"key":"4511_CR15","doi-asserted-by":"publisher","unstructured":"Pierce K, Gaskins J, Martin Ii RCG. The Weight of Nutrition on Post\u2013Resection Oncologic Morbidity and Mortality: A Systematic Review and Meta\u2013Analysis of Nutritional Indices. Nutr Rev. 2025;83(6):988\u20131005. https:\/\/doi.org\/10.1093\/nutrit\/nuae138. PMID: 39405175.","DOI":"10.1093\/nutrit\/nuae138"},{"issue":"22","key":"4511_CR16","doi-asserted-by":"publisher","first-page":"e15280","DOI":"10.1097\/MD.0000000000015280","volume":"98","author":"P Li","year":"2019","unstructured":"Li P, Wang X, Lai Y, Zhou K, Tang Y, Che G. The prognostic value of pre\u2013treatment prognostic nutritional index in esophageal squamous cell carcinoma: A meta\u2013analysis. Med (Baltim). 2019;98(22):e15280. PMID: 31145271; PMCID: PMC6709023.","journal-title":"Med (Baltim)"},{"issue":"11","key":"4511_CR17","doi-asserted-by":"publisher","first-page":"19655","DOI":"10.1002\/jcp.28565","volume":"234","author":"Y Xue","year":"2019","unstructured":"Xue Y, Zhou X, Xue L, Zhou R, Luo J. The role of pretreatment prognostic nutritional index in esophageal cancer: a meta\u2013analysis. J Cell Physiol. 2019;234(11):19655\u201362. https:\/\/doi.org\/10.1002\/jcp.28565.","journal-title":"J Cell Physiol"},{"key":"4511_CR18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3389\/fonc.2020.00797","volume":"10","author":"J Hao","year":"2020","unstructured":"Hao J, Chen C, Wan F, Zhu Y, Jin H, Zhou J, Chen N, Yang J, Pu Q. Prognostic Value of Pre\u2013Treatment Prognostic Nutritional Index in Esophageal Cancer: A Systematic Review and Meta\u2013Analysis. Front Oncol. 2020;10:797. https:\/\/doi.org\/10.3389\/fonc.2020.00797 . PMID: 32626652; PMCID: PMC7311778.","journal-title":"Front Oncol"},{"key":"4511_CR19","doi-asserted-by":"publisher","unstructured":"Takao K, Konishi H, Fujiwara H, Shiozaki A, Shoda K, Kosuga T, Kubota T, Arita T, Morimura R, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Okamoto K, Otsuji E. Clinical Significance of Prognostic Nutritional Index in the Treatment of Esophageal Squamous Cell Carcinoma. In Vivo. 2020 Nov\u2013Dec;34(6):3451\u20133457. https:\/\/doi.org\/10.21873\/invivo.12184. PMID: 33144453; PMCID: PMC7811656.","DOI":"10.21873\/invivo.12184"},{"key":"4511_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2147\/CMAR.S465501","volume":"16","author":"W Zou","year":"2024","unstructured":"Zou W, Kuang W, Cai C, Qian Y. Prognostic Nutritional Index as a Prognostic Indicator for the Occurrence of Postoperative Complications in Patients with Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy. Cancer Manag Res. 2024;16:643\u201350. PMID: 38919874; PMCID: PMC11197999.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"4511_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.17305\/bjbms.2022.7696","volume":"23","author":"J Feng","year":"2023","unstructured":"Feng J, Wang L, Yang X, Chen Q, Cheng X. Prediction of pathologic complete response prediction in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy: A real\u2013world study. Biomol Biomed. 2023;23(1):153\u201360. PMID: 35880397; PMCID: PMC9901900.","journal-title":"Biomol Biomed"},{"issue":"8","key":"4511_CR22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/dote.12533","volume":"29","author":"TW Rice","year":"2016","unstructured":"Rice TW, Ishwaran H, Hofstetter WL, Kelsen DP, Apperson\u2013Hansen C, Blackstone EH, Worldwide Esophageal Cancer Collaboration Investigators. Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC\/UICC staging manuals. Dis Esophagus. 2016;29(8):897\u2013905. https:\/\/doi.org\/10.1111\/dote.12533 . PMID: 27905172; PMCID: PMC5591444.","journal-title":"Dis Esophagus"},{"key":"4511_CR23","doi-asserted-by":"publisher","unstructured":"Low DE, Alderson D, Cecconello I, Chang AC, Darling GE, D\u02bcJourno XB, Griffin SM, H\u00f6lscher AH, Hofstetter WL, Jobe BA, Kitagawa Y, Kucharczuk JC, Law SY, Lerut TE, Maynard N, Pera M, Peters JH, Pramesh CS, Reynolds JV, Smithers BM, van Lanschot JJ. International Consensus on Standardization of Data Collection for Complications Associated with Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg. 2015;262(2):286\u201394. https:\/\/doi.org\/10.1097\/SLA.0000000000001098. PMID: 25607756.","DOI":"10.1097\/SLA.0000000000001098"},{"key":"4511_CR24","doi-asserted-by":"publisher","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santiba\u00f1es E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien\u2013Dindo classification of surgical complications: five\u2013year experience. Ann Surg. 2009;250(2):187\u201396. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b13ca2. PMID: 19638912.","DOI":"10.1097\/SLA.0b013e3181b13ca2"},{"issue":"1","key":"4511_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13048-025-01624-3","volume":"18","author":"X Liu","year":"2025","unstructured":"Liu X, Li M, Zhao Y, Jiao X, Yu Y, Li R, Zeng S, Chi J, Ma G, Huo Y, Peng Z, Liu J, Zhou Q, Zou D, Wang L, Li Q, Wang J, Yao S, Chen Y, Ma D, Hu T, Gao Q. The impact of preoperative immunonutritional status on postoperative complications in ovarian cancer. J Ovarian Res. 2025;18(1):88. https:\/\/doi.org\/10.1186\/s13048-025-01624-3 . PMID: 40301987; PMCID: PMC12038932.","journal-title":"J Ovarian Res"},{"key":"4511_CR26","doi-asserted-by":"publisher","unstructured":"McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009;12(3):223\u20136. https:\/\/doi.org\/10.1097\/MCO.0b013e32832a7902. PMID: 19318937.","DOI":"10.1097\/MCO.0b013e32832a7902"},{"issue":"5","key":"4511_CR27","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/00000658-197411000-00010","volume":"180","author":"TT Irvin","year":"1974","unstructured":"Irvin TT, Hunt TK. Effect of malnutrition on colonic healing. Ann Surg. 1974;180(5):765\u201372. https:\/\/doi.org\/10.1097\/00000658-197411000-00010 . PMID: 4418508; PMCID: PMC1343690.","journal-title":"Ann Surg"},{"key":"4511_CR28","doi-asserted-by":"publisher","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer\u2013related inflammation. Nature. 2008;454(7203):436\u201344. https:\/\/doi.org\/10.1038\/nature07205. PMID: 18650914.","DOI":"10.1038\/nature07205"},{"issue":"1","key":"4511_CR29","doi-asserted-by":"publisher","first-page":"22241","DOI":"10.1038\/s41598-025-08123-x","volume":"15","author":"P Yang","year":"2025","unstructured":"Yang P, Liu L, Yang Z, Zhang BF. Threshold effect of prognostic nutritional index on mortality in geriatric hip fracture patients. Sci Rep. 2025;15(1):22241. https:\/\/doi.org\/10.1038\/s41598-025-08123-x . PMID: 40596547; PMCID: PMC12216360.","journal-title":"Sci Rep"},{"issue":"1","key":"4511_CR30","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1186\/s12885-025-14478-1","volume":"25","author":"C Chen","year":"2025","unstructured":"Chen C, Wang J, Li Y. A nomogram model to predict postoperative delirium in esophageal cancer patients undergoing esophagectomy. BMC Cancer. 2025;25(1):1082. https:\/\/doi.org\/10.1186\/s12885-025-14478-1 . PMID: 40597926; PMCID: PMC12211344.","journal-title":"BMC Cancer"},{"key":"4511_CR31","doi-asserted-by":"publisher","unstructured":"Okadome K, Baba Y, Yagi T, Kiyozumi Y, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Watanabe M, Baba H. Prognostic Nutritional Index, Tumor\u2013infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer. Ann Surg. 2020;271(4):693\u2013700. https:\/\/doi.org\/10.1097\/SLA.0000000000002985. PMID: 30308614.","DOI":"10.1097\/SLA.0000000000002985"},{"issue":"2","key":"4511_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00262-022-03265-7","volume":"72","author":"T Ikoma","year":"2023","unstructured":"Ikoma T, Shimokawa M, Matsumoto T, Boku S, Yasuda T, Shibata N, Kurioka Y, Takatani M, Nobuhisa T, Namikawa T, Kitagawa H, Hanazaki K, Doi K, Shimada T, Tsumura T, Marusawa H, Kanaya S, Morita S, Inokuma T, Nagai H, Yasui H, Satake H. Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab. Cancer Immunol Immunother. 2023;72(2):427\u201335. https:\/\/doi.org\/10.1007\/s00262-022-03265-7 . Epub 2022 Aug 4. PMID: 35927359; PMCID: PMC10992512.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"4511_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12885-025-13600-7","volume":"25","author":"Y Dong","year":"2025","unstructured":"Dong Y, Wang F, Deng J, Tong T, Chen X, Wu L, Wang Y, Kang M, Xu Y, Shi G, Zhu L. Prognostic value of serum inflammatory markers in patients with esophageal squamous cell carcinoma undergoing surgery: a two\u2013center retrospective cohort study. BMC Cancer. 2025;25(1):213. https:\/\/doi.org\/10.1186\/s12885-025-13600-7 . PMID: 39920653; PMCID: PMC11804429.","journal-title":"BMC Cancer"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-04511-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04511-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04511-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:26:56Z","timestamp":1791980816000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-04511-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,19]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4511"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-04511-0","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,19]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013) and was approved by the Ethics Committee of Affiliated Hospital of Putian University. The requirement for individual informed consent was waived due to the retrospective nature of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"779"}}